DK0835254T3 - Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse - Google Patents

Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse

Info

Publication number: DK0835254T3
Authority: DK; Denmark
Prior art keywords: preparation; therapeutic use; oxazolidinone derivatives; oxazolidinone; derivatives
Prior art date: 1995-06-02

Application number

DK96918719T

Other languages

Danish (da)

English (en)

Inventor

Samir Jegham

Frederic Puech

Philippe Burnier

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-02

Filing date

1996-05-28

Publication date

2000-03-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0835254(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-06-02 Priority claimed from FR9506563A external-priority patent/FR2734820B1/fr

1995-06-02 Priority claimed from FR9506564A external-priority patent/FR2734821B1/fr

1996-05-28 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2000-03-27 Application granted granted Critical

2000-03-27 Publication of DK0835254T3 publication Critical patent/DK0835254T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK96918719T 1995-06-02 1996-05-28 Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse DK0835254T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9506563A FR2734820B1 (fr)	1995-06-02	1995-06-02	Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR9506564A FR2734821B1 (fr)	1995-06-02	1995-06-02	Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
PCT/FR1996/000792 WO1996038444A1 (fr)	1995-06-02	1996-05-28	Derives d'oxazolidinone, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
DK0835254T3 true DK0835254T3 (da)	2000-03-27

Family

ID=26232004

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96918719T DK0835254T3 (da)	1995-06-02	1996-05-28	Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse

Country Status (27)

Country	Link
US (1)	US5843975A (xx)
EP (1)	EP0835254B1 (xx)
JP (1)	JP3856829B2 (xx)
KR (1)	KR100457502B1 (xx)
CN (1)	CN1075072C (xx)
AR (1)	AR006301A1 (xx)
AT (1)	ATE184005T1 (xx)
AU (1)	AU699367B2 (xx)
BR (1)	BR9608896A (xx)
CA (1)	CA2223011C (xx)
CO (1)	CO4700462A1 (xx)
CZ (1)	CZ378497A3 (xx)
DE (1)	DE69604071T2 (xx)
DK (1)	DK0835254T3 (xx)
ES (1)	ES2138346T3 (xx)
GR (1)	GR3031710T3 (xx)
HK (1)	HK1014938A1 (xx)
HU (1)	HU224879B1 (xx)
MX (1)	MX9709410A (xx)
NO (1)	NO309091B1 (xx)
NZ (1)	NZ310487A (xx)
PL (1)	PL183919B1 (xx)
RU (1)	RU2164226C2 (xx)
SK (1)	SK281934B6 (xx)
TW (1)	TW360654B (xx)
WO (1)	WO1996038444A1 (xx)
ZA (1)	ZA964563B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1078632A1 (en) *	1999-08-16	2001-02-28	Sanofi-Synthelabo	Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
SK9562003A3 (en) *	2001-01-31	2004-04-06	Synaptic Pharma Corp	Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
IL160744A0 (en) *	2001-09-26	2004-08-31	Pharmacia Italia Spa	Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
JP2009525318A (ja) *	2006-02-01	2009-07-09	ファイザー・プロダクツ・インク	抗菌剤としてのベンズイソオキサゾールオキサゾリジノン
WO2008120655A1 (ja) *	2007-03-30	2008-10-09	Institute Of Medicinal Molecular Design, Inc.	Ｉ型１１βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体
EP2123159A1 (de) *	2008-05-21	2009-11-25	Bayer CropScience AG	(1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide
WO2011075565A1 (en) *	2009-12-18	2011-06-23	Janssen Pharmaceutica Nv	SUBSTITUTED AMINOTHIAZOLONE INDAZOLES AS ESTROGEN RELATED RECEPTOR-Aα MODULATORS
MX2012009528A (es) *	2010-02-17	2013-01-14	Janssen Pharmaceutica Nv	Aminotiazolonas como moduladores de receptores alfa relacionados con el estrógeno.
WO2016097355A1 (en) *	2014-12-19	2016-06-23	Ge Healthcare Limited	Labelled oxazolidinone derivatives
DE102015012050A1 (de) *	2015-09-15	2017-03-16	Merck Patent Gmbh	Verbindungen als ASIC-Inhibitoren und deren Verwendungen
RU2637643C1 (ru) *	2016-09-05	2017-12-05	Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ)	Иммунодепрессант

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5196543A (en) *	1989-10-17	1993-03-23	Delalande S.A.	3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
FR2653017B1 (fr) *	1989-10-17	1995-05-05	Delalande Sa	Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5235063A (en) *	1989-10-17	1993-08-10	Delalande S.A.	Process of preparing by condensation certain
US5182296A (en) *	1989-10-26	1993-01-26	Tanabe Seiyaky Co., Ltd.	Naphthyloxazolidone derivatives
FR2671350A1 (fr) *	1991-01-08	1992-07-10	Adir	Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
CA2079906A1 (en) *	1991-02-20	1992-08-21	Yusaku Koda	Articulator

1996
- 1996-05-28 HU HU9901349A patent/HU224879B1/hu unknown
- 1996-05-28 US US08/973,246 patent/US5843975A/en not_active Expired - Lifetime
- 1996-05-28 EP EP96918719A patent/EP0835254B1/fr not_active Expired - Lifetime
- 1996-05-28 JP JP53624596A patent/JP3856829B2/ja not_active Expired - Lifetime
- 1996-05-28 DE DE69604071T patent/DE69604071T2/de not_active Expired - Lifetime
- 1996-05-28 CZ CZ973784A patent/CZ378497A3/cs unknown
- 1996-05-28 PL PL96323673A patent/PL183919B1/pl unknown
- 1996-05-28 NZ NZ310487A patent/NZ310487A/xx not_active IP Right Cessation
- 1996-05-28 CA CA002223011A patent/CA2223011C/en not_active Expired - Lifetime
- 1996-05-28 BR BR9608896A patent/BR9608896A/pt active IP Right Grant
- 1996-05-28 RU RU98100257/04A patent/RU2164226C2/ru active
- 1996-05-28 KR KR1019970708666A patent/KR100457502B1/ko not_active IP Right Cessation
- 1996-05-28 ES ES96918719T patent/ES2138346T3/es not_active Expired - Lifetime
- 1996-05-28 WO PCT/FR1996/000792 patent/WO1996038444A1/fr active IP Right Grant
- 1996-05-28 DK DK96918719T patent/DK0835254T3/da active
- 1996-05-28 CN CN96195713A patent/CN1075072C/zh not_active Expired - Lifetime
- 1996-05-28 SK SK1614-97A patent/SK281934B6/sk not_active IP Right Cessation
- 1996-05-28 AT AT96918719T patent/ATE184005T1/de active
- 1996-05-28 AU AU61288/96A patent/AU699367B2/en not_active Expired
- 1996-05-31 CO CO96028173A patent/CO4700462A1/es unknown
- 1996-06-01 TW TW085106564A patent/TW360654B/zh not_active IP Right Cessation
- 1996-06-03 ZA ZA964563A patent/ZA964563B/xx unknown
- 1996-06-03 AR ARP960102870A patent/AR006301A1/es active IP Right Grant
1997
- 1997-12-01 NO NO975530A patent/NO309091B1/no not_active IP Right Cessation
- 1997-12-02 MX MX9709410A patent/MX9709410A/es unknown
1998
- 1998-12-30 HK HK98119245A patent/HK1014938A1/xx not_active IP Right Cessation
1999
- 1999-11-03 GR GR990402802T patent/GR3031710T3/el unknown

Also Published As

Publication number	Publication date
DE69604071T2 (de)	2000-04-06
WO1996038444A1 (fr)	1996-12-05
TW360654B (en)	1999-06-11
DE69604071D1 (de)	1999-10-07
CA2223011A1 (en)	1996-12-05
ATE184005T1 (de)	1999-09-15
KR100457502B1 (ko)	2005-09-05
NZ310487A (en)	1999-05-28
RU2164226C2 (ru)	2001-03-20
HUP9901349A3 (en)	2000-02-28
ZA964563B (en)	1996-12-12
HUP9901349A2 (hu)	1999-08-30
NO975530D0 (no)	1997-12-01
SK161497A3 (en)	1998-05-06
PL323673A1 (en)	1998-04-14
AU6128896A (en)	1996-12-18
CN1191534A (zh)	1998-08-26
CZ378497A3 (cs)	1998-04-15
SK281934B6 (sk)	2001-09-11
AU699367B2 (en)	1998-12-03
HK1014938A1 (en)	1999-10-08
GR3031710T3 (en)	2000-02-29
EP0835254A1 (fr)	1998-04-15
CA2223011C (en)	2007-01-09
NO975530L (no)	1998-02-02
EP0835254B1 (fr)	1999-09-01
PL183919B1 (pl)	2002-08-30
KR19990022187A (ko)	1999-03-25
AR006301A1 (es)	1999-08-25
HU224879B1 (en)	2006-03-28
NO309091B1 (no)	2000-12-11
CO4700462A1 (es)	1998-12-29
BR9608896A (pt)	1999-06-29
JPH11507330A (ja)	1999-06-29
MX9709410A (es)	1998-07-31
ES2138346T3 (es)	2000-01-01
JP3856829B2 (ja)	2006-12-13
US5843975A (en)	1998-12-01
CN1075072C (zh)	2001-11-21

Publication	Publication Date	Title
DK0869126T3 (da)	2002-11-18	Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO954369L (no)	1996-05-03	Oksazolidindionderivater, deres fremstilling og anvendelse
DK0832104T3 (da)	2003-01-06	Dolastatinderivater, deres fremstilling og anvendelse
NO961160D0 (no)	1996-03-21	Cykliske forbindelser, deres fremstilling og anvendelse
NO980720D0 (no)	1998-02-20	Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO951095L (no)	1995-09-25	Tiazolidin- og oksazolidinderivater, deres fremstilling og medisinske bruk
NO943682D0 (no)	1994-10-03	Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO924650D0 (no)	1992-12-02	Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
DK1161434T3 (da)	2003-05-26	Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO961721D0 (no)	1996-04-29	2-oksetanon-limingsmidler, deres fremstilling og bruk
NO955326D0 (no)	1995-12-28	Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO955305D0 (no)	1995-12-27	Optisk aktive benzotiepinderivater, deres fremstilling og anvendelse
NO975020D0 (no)	1997-10-31	Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
NO962477D0 (no)	1996-06-12	Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO992676D0 (no)	1999-06-02	1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DK0835254T3 (da)	2000-03-27	Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO20001934D0 (no)	2000-04-13	3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO940130D0 (no)	1994-01-14	Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO921563D0 (no)	1992-04-23	Terapeutisk aktive aminopyrimidinderivater, fremgangsmaatefor deres fremstilling og anvendelse derav
NO955242D0 (no)	1995-12-22	Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO980471L (no)	1998-04-06	Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
NO20000066D0 (no)	2000-01-06	6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO982549D0 (no)	1998-06-04	5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
NO950560D0 (no)	1995-02-15	Piperazinderivater, deres fremstilling og terapautiske anvendelse
NO992436D0 (no)	1999-05-20	N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse